Ransomware hackers target NHS hospitals with new cyberattacks – Go Health Pro

Ransomware hackers target NHS hospitals with new cyberattacks – Go Health Pro

Ransomware hackers have continued an assault on National Health Service trusts across the United Kingdom by compromising multiple hospitals, exposing sensitive patient data, and disrupting emergency services. Inc Ransom, a prolific Russia-linked ransomware group that claimed responsibility for an attack on NHS Scotland earlier this year, now claims to have breached the Alder Hey Children’s … Read more

Tech Support Scams Exploit Google Ads to Target Users – Go Health Pro

Tech Support Scams Exploit Google Ads to Target Users – Go Health Pro

It’s not a new technique, but that doesn’t mean that cybercriminals cannot make rich rewards from SEO poisoning.  SEO poisoning is the dark art of manipulating search engines to ensure that malware-laced adverts and dangerous websites appear high on users’ results – often impersonating legitimate businesses and organisations.  But the simplest way of all to … Read more

Zacks Small Cap Research – FBLG: On Target to Initiate Phase 1/2 Trial in 2025… – Go Health Pro

By David Bautz, PhD NASDAQ:FBLG READ THE FULL FBLG RESEARCH REPORT Business Update On Track to Initiate Phase 1/2 Trial in Diabetic Foot Ulcers FibroBiologics, Inc. (NASDAQ:FBLG) is on track to initiate a Phase 1/2 trial of CYWC628, a fibroblast-based spheroid product candidate, in patients suffering from diabetic foot ulcers (DFU) in the second quarter … Read more

Zacks Small Cap Research – MGRM: Monogram’s Potential for Profitable Long-Term Growth Supports Price Target of $6.00. – Go Health Pro

By Thomas Kerr, CFA NASDAQ:MGRM READ THE FULL MGRM RESEARCH REPORT Monogram (NASDAQ:MGRM) reported 3rd quarter 2024 financial results on November 14th which were largely in line with expectations. Research and development expenses for the quarter ending September 30, 2024 were $2.2 million compared to $2.7 million in the prior year period. The R&D decrease … Read more

Zacks Small Cap Research – TWI: Titan International Free Cash Flow Generation Over the Long Term Supports Price Target of $16.00 – Go Health Pro

By Thomas Kerr, CFA NYSE:TWI READ THE FULL TWI RESEARCH REPORT 3rd Quarter 2024 Financial and Operating Results Titan International (NYSE:TWI) reported 3rd quarter 2024 financial results which continued to reflect a difficult macro environment in most of its end markets as the OEM destocking story continues to evolve. Net sales for the 3rd quarter … Read more